Nuravax
PrivateLast Round
Grant
May 5, 2025
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuravax operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Grant round in May 2025.
Nuravax is a biotechnology company that engineers precision immunotherapies to prevent and cure Alzheimer's and Parkinson's diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuravax Comparables
Compare Nuravax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxxinity, Inc. | 79% | |
| Axon Neuroscience | 78% | |
| Grifols | 77% |
For institutional investors. Book with your work email.
Nuravax Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuravax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 537% MoM, reaching 1.7K.
- Apr 16, 2026
Monthly visitors grew 150% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Nuravax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuravax's valuation, stock price, and market status.
Is Nuravax a public or private company?
Nuravax is a private company.
What is the current stock price of Nuravax?
Nuravax is a private company, so its shares have no public market price. Caplight tracks Nuravax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuravax worth (valuation)?
Valuation information for Nuravax is not publicly available.
Can I buy Nuravax stock?
Nuravax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuravax's last funding round?
Nuravax's most recent funding round was Grant on May 5, 2025.
Who are the main investors in Nuravax?
Key investors in Nuravax include NIH RADx.
Will Nuravax IPO soon?
No public IPO plans have been announced for Nuravax.
How can I track Nuravax secondary market activity?
Caplight tracks bids, offers, and trades in Nuravax's shares on secondary markets.